Fiscal Reports. If Collaborator has agreed to provide funding to CDC under this CRADA and upon the request of Collaborator, then concurrent with the exchange of final research and development reports according to Paragraph 4.2, CDC will submit to Collaborator a statement of all costs incurred by CDC for the CRADA. If the CRADA has been terminated, CDC will specify any costs incurred before the date of termination for which CDC has not received funds from Collaborator, as well as for all reasonable termination costs including the cost of returning Collaborator property or removal of abandoned Collaborator property, for which Collaborator will be responsible.
Appears in 4 contracts
Samples: Public Health Service, Public Health Service, Public Health Service
Fiscal Reports. If Collaborator has agreed to provide funding to CDC FDA under this CRADA and upon the request of Collaborator, then concurrent with the exchange of final research and development reports according to Paragraph 4.2, CDC FDA will submit to Collaborator a statement of all costs incurred by CDC FDA for the CRADA. If the CRADA has been terminated, CDC FDA will specify any costs incurred before the date of termination for which CDC FDA has not received funds from Collaborator, as well as for all reasonable termination costs including the cost of returning Collaborator property or removal of abandoned Collaborator property, for which Collaborator will be responsible.
Appears in 1 contract